Monday, February 24, 2025 11:55:13 PM
Krisgo, while I don't believe LP has intentionally kept the price down, but I do agree she'll have many more shares. The good news is that we've had the opportunity to share in these low prices.
I know I own more shares than I ever dreamed of having and I suspect that's true of many here.
With an approval occurring any day, I believe our market cap ought to be somewhere in the $1 to $3 billion range, which is at least 3 times to 9 times what it is today. Post approval I think the $2 to $5 billion market cap should apply.
I don't believe the MM's and shorts will be able to hold the share price down post approval, especially if we get the right kind of media coverage.
At something above $5 we may be overpriced, but if other news is out, and positive, perhaps not. In other stocks I've seen big media coverage result in a feeding frenzy that took stock prices to totally unrealistic levels, and invariably the stock fell back to earth, that's where setting trailing stop loss orders can work well. I'm not a trader, I generally won't buy and sell, but if we're into double digits I will set trailing stop losses for much, if not all my shares. Depending on whether we get additional news that goes beyond UK approval I would expect to be able to buy the stock back somewhere between $3 and $5 if it peaks at or near double digit prices.
Meanwhile, as I said, by at least a few hundred thousand shares I have much more than I ever dreamed of buying. That wouldn't have happened if after the NYAS presentation the stock traded for $1 or more, which I believe it should have had it not been for the concerted efforts of AdamF, the 7 MM's, and the shorts.
Gary
I know I own more shares than I ever dreamed of having and I suspect that's true of many here.
With an approval occurring any day, I believe our market cap ought to be somewhere in the $1 to $3 billion range, which is at least 3 times to 9 times what it is today. Post approval I think the $2 to $5 billion market cap should apply.
I don't believe the MM's and shorts will be able to hold the share price down post approval, especially if we get the right kind of media coverage.
At something above $5 we may be overpriced, but if other news is out, and positive, perhaps not. In other stocks I've seen big media coverage result in a feeding frenzy that took stock prices to totally unrealistic levels, and invariably the stock fell back to earth, that's where setting trailing stop loss orders can work well. I'm not a trader, I generally won't buy and sell, but if we're into double digits I will set trailing stop losses for much, if not all my shares. Depending on whether we get additional news that goes beyond UK approval I would expect to be able to buy the stock back somewhere between $3 and $5 if it peaks at or near double digit prices.
Meanwhile, as I said, by at least a few hundred thousand shares I have much more than I ever dreamed of buying. That wouldn't have happened if after the NYAS presentation the stock traded for $1 or more, which I believe it should have had it not been for the concerted efforts of AdamF, the 7 MM's, and the shorts.
Gary
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
